(ARMK) Aramark Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US03852U1060
Stock: Food Services, Facility Management, Support Services, Catering
Total Rating 47
Risk 68
Buy Signal 0.18
| Risk 5d forecast | |
|---|---|
| Volatility | 26.2% |
| Relative Tail Risk | -7.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.47 |
| Alpha | -0.26 |
| Character TTM | |
|---|---|
| Beta | 0.778 |
| Beta Downside | 0.792 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.63% |
| CAGR/Max DD | 0.68 |
EPS (Earnings per Share)
Revenue
Description: ARMK Aramark Holdings March 04, 2026
Aramark (ARMK) provides food and facilities services across diverse sectors including education, healthcare, and sports. The company operates through U.S. and International segments.
The business model centers on managed services. This includes dining, catering, and retail food services. It also encompasses non-clinical support services and facility management services like maintenance and housekeeping. Diversification across multiple client types is common in the contract food service industry.
Additionally, Aramark offers specialized services for correctional facilities, such as food and commissary operations. Understanding the full scope of Aramarks service offerings can be enhanced by further research on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 316.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.97 > 1.0 |
| NWC/Revenue: 4.14% < 20% (prev -1.15%; Δ 5.29% < -1%) |
| CFO/TA 0.05 > 3% & CFO 726.0m > Net Income 316.9m |
| Net Debt (6.40b) to EBITDA (1.27b): 5.04 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (266.3m) vs 12m ago -0.87% < -2% |
| Gross Margin: 6.98% > 18% (prev 0.08%; Δ 689.9% > 0.5%) |
| Asset Turnover: 143.1% > 50% (prev 138.1%; Δ 5.05% > 0%) |
| Interest Coverage Ratio: 2.20 > 6 (EBITDA TTM 1.27b / Interest Expense TTM 355.0m) |
Altman Z'' 0.94
| A: 0.06 (Total Current Assets 3.63b - Total Current Liabilities 2.86b) / Total Assets 13.54b |
| B: 0.04 (Retained Earnings 515.8m / Total Assets 13.54b) |
| C: 0.06 (EBIT TTM 779.7m / Avg Total Assets 13.12b) |
| D: 0.04 (Book Value of Equity 368.8m / Total Liabilities 10.31b) |
| Altman-Z'' Score: 0.94 = BB |
Beneish M -2.80
| DSRI: 1.06 (Receivables 2.50b/2.20b, Revenue 18.79b/17.55b) |
| GMI: 1.19 (GM 6.98% / 8.34%) |
| AQI: 0.97 (AQ_t 0.54 / AQ_t-1 0.56) |
| SGI: 1.07 (Revenue 18.79b / 17.55b) |
| TATA: -0.03 (NI 316.9m - CFO 726.0m) / TA 13.54b) |
| Beneish M-Score: -2.80 (Cap -4..+1) = A |
What is the price of ARMK shares?
As of March 07, 2026, the stock is trading at USD 40.25 with a total of 2,616,164 shares traded.
Over the past week, the price has changed by -3.82%, over one month by +4.24%, over three months by +9.35% and over the past year by +14.57%.
Over the past week, the price has changed by -3.82%, over one month by +4.24%, over three months by +9.35% and over the past year by +14.57%.
Is ARMK a buy, sell or hold?
Aramark Holdings has received a consensus analysts rating of 4.43.
Therefore, it is recommended to buy ARMK.
- StrongBuy: 8
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ARMK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.6 | 15.9% |
| Analysts Target Price | 46.6 | 15.9% |
ARMK Fundamental Data Overview March 05, 2026
P/E Trailing = 34.3361
P/E Forward = 18.9036
P/S = 0.5717
P/B = 3.3804
P/EG = 1.0449
Revenue TTM = 18.79b USD
EBIT TTM = 779.7m USD
EBITDA TTM = 1.27b USD
Long Term Debt = 6.21b USD (from longTermDebt, last quarter)
Short Term Debt = 98.8m USD (from shortTermDebt, last quarter)
Debt = 6.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.40b USD (from netDebt column, last quarter)
Enterprise Value = 17.13b USD (10.74b + Debt 6.84b - CCE 439.6m)
Interest Coverage Ratio = 2.20 (Ebit TTM 779.7m / Interest Expense TTM 355.0m)
EV/FCF = 66.64x (Enterprise Value 17.13b / FCF TTM 257.1m)
FCF Yield = 1.50% (FCF TTM 257.1m / Enterprise Value 17.13b)
FCF Margin = 1.37% (FCF TTM 257.1m / Revenue TTM 18.79b)
Net Margin = 1.69% (Net Income TTM 316.9m / Revenue TTM 18.79b)
Gross Margin = 6.98% ((Revenue TTM 18.79b - Cost of Revenue TTM 17.47b) / Revenue TTM)
Gross Margin QoQ = 6.01% (prev 5.78%)
Tobins Q-Ratio = 1.27 (Enterprise Value 17.13b / Total Assets 13.54b)
Interest Expense / Debt = 1.30% (Interest Expense 88.9m / Debt 6.84b)
Taxrate = 28.85% (39.1m / 135.6m)
NOPAT = 554.7m (EBIT 779.7m * (1 - 28.85%))
Current Ratio = 1.27 (Total Current Assets 3.63b / Total Current Liabilities 2.86b)
Debt / Equity = 2.13 (Debt 6.84b / totalStockholderEquity, last quarter 3.21b)
Debt / EBITDA = 5.04 (Net Debt 6.40b / EBITDA 1.27b)
Debt / FCF = 24.87 (Net Debt 6.40b / FCF TTM 257.1m)
Total Stockholder Equity = 3.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.41% (Net Income 316.9m / Total Assets 13.54b)
RoE = 10.17% (Net Income TTM 316.9m / Total Stockholder Equity 3.12b)
RoCE = 8.36% (EBIT 779.7m / Capital Employed (Equity 3.12b + L.T.Debt 6.21b))
RoIC = 6.01% (NOPAT 554.7m / Invested Capital 9.24b)
WACC = 5.73% (E(10.74b)/V(17.57b) * Re(8.78%) + D(6.84b)/V(17.57b) * Rd(1.30%) * (1-Tc(0.29)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.39%
[DCF] Terminal Value 87.48% ; FCFF base≈300.2m ; Y1≈339.7m ; Y5≈460.7m
[DCF] Fair Price = 27.27 (EV 13.56b - Net Debt 6.40b = Equity 7.17b / Shares 262.8m; r=5.90% [WACC]; 5y FCF grow 15.35% → 2.90% )
EPS Correlation: 51.87 | EPS CAGR: 25.13% | SUE: 0.0 | # QB: 0
Revenue Correlation: 72.77 | Revenue CAGR: 6.17% | SUE: 0.97 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=-0.008 | Chg30d=-0.008 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-09-30): EPS=2.23 | Chg7d=+0.008 | Chg30d=+0.008 | Revisions Net=+4 | Growth EPS=+22.2% | Growth Revenue=+7.0%
EPS next Year (2027-09-30): EPS=2.62 | Chg7d=+0.026 | Chg30d=+0.026 | Revisions Net=+5 | Growth EPS=+17.6% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: -0.25 (3 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 8.8% - Earnings Yield 2.9%)
[Growth] Growth Spread = -0.3% (Analyst 5.6% - Implied 5.9%)
P/E Forward = 18.9036
P/S = 0.5717
P/B = 3.3804
P/EG = 1.0449
Revenue TTM = 18.79b USD
EBIT TTM = 779.7m USD
EBITDA TTM = 1.27b USD
Long Term Debt = 6.21b USD (from longTermDebt, last quarter)
Short Term Debt = 98.8m USD (from shortTermDebt, last quarter)
Debt = 6.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.40b USD (from netDebt column, last quarter)
Enterprise Value = 17.13b USD (10.74b + Debt 6.84b - CCE 439.6m)
Interest Coverage Ratio = 2.20 (Ebit TTM 779.7m / Interest Expense TTM 355.0m)
EV/FCF = 66.64x (Enterprise Value 17.13b / FCF TTM 257.1m)
FCF Yield = 1.50% (FCF TTM 257.1m / Enterprise Value 17.13b)
FCF Margin = 1.37% (FCF TTM 257.1m / Revenue TTM 18.79b)
Net Margin = 1.69% (Net Income TTM 316.9m / Revenue TTM 18.79b)
Gross Margin = 6.98% ((Revenue TTM 18.79b - Cost of Revenue TTM 17.47b) / Revenue TTM)
Gross Margin QoQ = 6.01% (prev 5.78%)
Tobins Q-Ratio = 1.27 (Enterprise Value 17.13b / Total Assets 13.54b)
Interest Expense / Debt = 1.30% (Interest Expense 88.9m / Debt 6.84b)
Taxrate = 28.85% (39.1m / 135.6m)
NOPAT = 554.7m (EBIT 779.7m * (1 - 28.85%))
Current Ratio = 1.27 (Total Current Assets 3.63b / Total Current Liabilities 2.86b)
Debt / Equity = 2.13 (Debt 6.84b / totalStockholderEquity, last quarter 3.21b)
Debt / EBITDA = 5.04 (Net Debt 6.40b / EBITDA 1.27b)
Debt / FCF = 24.87 (Net Debt 6.40b / FCF TTM 257.1m)
Total Stockholder Equity = 3.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.41% (Net Income 316.9m / Total Assets 13.54b)
RoE = 10.17% (Net Income TTM 316.9m / Total Stockholder Equity 3.12b)
RoCE = 8.36% (EBIT 779.7m / Capital Employed (Equity 3.12b + L.T.Debt 6.21b))
RoIC = 6.01% (NOPAT 554.7m / Invested Capital 9.24b)
WACC = 5.73% (E(10.74b)/V(17.57b) * Re(8.78%) + D(6.84b)/V(17.57b) * Rd(1.30%) * (1-Tc(0.29)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.39%
[DCF] Terminal Value 87.48% ; FCFF base≈300.2m ; Y1≈339.7m ; Y5≈460.7m
[DCF] Fair Price = 27.27 (EV 13.56b - Net Debt 6.40b = Equity 7.17b / Shares 262.8m; r=5.90% [WACC]; 5y FCF grow 15.35% → 2.90% )
EPS Correlation: 51.87 | EPS CAGR: 25.13% | SUE: 0.0 | # QB: 0
Revenue Correlation: 72.77 | Revenue CAGR: 6.17% | SUE: 0.97 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=-0.008 | Chg30d=-0.008 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-09-30): EPS=2.23 | Chg7d=+0.008 | Chg30d=+0.008 | Revisions Net=+4 | Growth EPS=+22.2% | Growth Revenue=+7.0%
EPS next Year (2027-09-30): EPS=2.62 | Chg7d=+0.026 | Chg30d=+0.026 | Revisions Net=+5 | Growth EPS=+17.6% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: -0.25 (3 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 8.8% - Earnings Yield 2.9%)
[Growth] Growth Spread = -0.3% (Analyst 5.6% - Implied 5.9%)